Showing 871-880 of 8663 results for "".
Scientifically Speaking: Rox Anderson, MD Talks Changing Lives Through Inventions
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-rox-anderson-md-talks-changing-lives-through-inventions/20140/Rox Anderson, MD has been at the forefront of inventions that have shaped the modern practice of dermatology. He discusses his inspirations and his desire to advance patient care. Host Joel L. Cohen, MD talks to him about his latest innovations and a recent recognition.Skin Cancer Perceptions, Cimzia for Psoriasis, Eczema and CV Risk
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-skin-cancer-perceptions-cimzia-for-psoriasis-eczema-and-cv-risk/18301/A new national survey, Skin Cancer In America 2018, conducted by Health Union, explores perceptions of patients with skin cancer. Cimzia (certolizumab pegol, UCB) has received FDA approval for treatment of adults with moderate to severe plaque psoriasis. Cimzia is the first Fc-free, PEGylated anti TConnective Tissue Disorders Update 2025: Dr. Vleugels
https://practicaldermatology.com/programs/practical-dermatology/connective-tissue-disorders-update-2025-dr-vleugels/32673/Ruth Ann Vleugels, MD, PhD, recaps her presentation, "Connective Tissue Disorders Update 2025" at Maui Derm 2025. Dr. Vleugels discussed a new therapeutic for systemic lupus, a new FDA-approved option for dermatomyositis, JAK inhibitors, and more.Addressing Skin Changes During Menopause: An Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/addressing-skin-changes-during-menopause-an-update/20220/New York City-based dermatologist Ellen Gendler, MD, shares pearls from her recent talk at the 2023 annual meeting of the Menopause Society including the current thinking on how to address the effects of diminished estrogen on skin.The Impact of Clascoterone Topical Cream, 1%
https://practicaldermatology.com/issues/april-2025/the-impact-of-clascoterone-topical-cream-1/35605/Clascoterone topical cream, 1% (Winlevi, Sun Pharmaceuticals, Inc.) approved by the US Food and Drug Administration (FDA) in 2020 as the first novel drug introduced for the treatment of acne vulgaris since 1982, is indicated in the US for patients 12 years of age and older.Taking Action: Quality of Care in AD
https://practicaldermatology.com/topics/atopic-dermatitis/taking-action-quality-of-care-in-ad/19881/Beyond identifying barriers to AD patient care, the Quality of Care in Atopic Dermatitis initiative presents potential solutions. Eric Simpson, MD, MCR outlines some key strategies for improving care and emphasizes that some simple steps can make a big difference.Content marketing in the age of COVID 19
https://practicaldermatology.com/topics/practice-management/content-marketing-in-the-age-of-covid-19/19836/COVID-19 has changed everything, probably including the way you promote your practice. Content marketing has become more challenging, and more important than ever. Check out this short video from Ekwa Marketing to learn what to do (and what not to do) for a successful content marketing strategy.Should I Recommend Products that Claim to Contain Probiotics?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/should-i-recommend-products-that-claim-to-contain-probiotics/19829/The language of the microbiome can be confusing. Dr. Friedman prefers to focus on symbiotics when making topical product recommendations.Chin Up
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/chin-up/19689/Placement of a small volume of filler in the chin can be the secret to creating an ideal aesthetic in the lower face, according to Sabrina Fabi, MD. She discusses the anatomy of the face and explains why this approach can be so successful.Cosmetic Bootcamp 2019: Presenter Recaps
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmetic-bootcamp-2019-presenter-recaps/19631/In its 15th year, Cosmetic Bootcamp continues to bring together core aesthetic physicians to earn about new and emerging interventions. Mary Lupo, MD; Jeanine Downie, MD; Jose Raul Montes, MD; Diane Berson, MD; Ava Shamban, MD; and Deborah Sherman, MD recap their presentations.